Ethr from mycobacterium tuberculosis in complex with compound bdm14744 Deposition Author(s): Aumercier, M. , Baulard, A.R. , Bifani, P. , Carette, X. , Delcroix, G. , Deprez, B. , Deprez-Poulain, R. , Desroses, M. , Dirie, B. , Frenois, F. , Leroux, F. , Locht, C. , Mathys, V. , Singhal, A. , Villeret, V. , Willand, N. , Willery, E.
Date: 2009-01-30 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3G1L_A
Ethr from mycobacterium tuberculosis in complex with compound bdm31381 Deposition Author(s): Aumercier, M. , Baulard, A.R. , Bifani, P. , Carette, X. , Delcroix, G. , Deprez, B. , Deprez-Poulain, R. , Desroses, M. , Dirie, B. , Frenois, F. , Leroux, F. , Locht, C. , Mathys, V. , Singhal, A. , Villeret, V. , Willand, N. , Willery, E.
Date: 2009-01-30 Method: X-RAY DIFFRACTION Resolution: 1.7 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3G1M_A
Ethr from mycobacterium tuberculosis in complex with compound bdm14500 Deposition Author(s): Aumercier, M. , Baulard, A.R. , Bifani, P. , Carette, X. , Delcroix, G. , Deprez, B. , Deprez-Poulain, R. , Desroses, M. , Dirie, B. , Frenois, F. , Leroux, F. , Locht, C. , Mathys, V. , Singhal, A. , Villeret, V. , Willand, N. , Willery, E.
Date: 2009-01-30 Method: X-RAY DIFFRACTION Resolution: 1.85 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3G1O_A
Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors. Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Date: 2011-06-09 Method: X-RAY DIFFRACTION Resolution: 1.87 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3SDG_A
Ethionamide boosters part 2: combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole ethr inhibitors. Deposition Author(s): Baulard, A.R. , Blondiaux, N. , Brodin, P. , Christophe, T. , D Prez, B. , Desroses, M. , Flament, M.P. , Flipo, M. , Jeon, H.K. , Lecat-Guillet, N. , Leroux, F. , Locht, C. , Mathys, V. , Piveteau, C. , Siepmann, J. , Soror, S.H. , Villemagne, B. , Villeret, V. , Willand, N. , Wintjens, R. , Wohlkonig, A.
Date: 2011-06-13 Method: X-RAY DIFFRACTION Resolution: 2.31 Å Organism(s): Mycobacterium Tuberculosis Sequences Data: 3SFI_A
Crystal structure of the mycobacterium tuberculosis regulator virs (n-terminal fragment 4-208) in complex with the drug candidate alpibectir Deposition Author(s): Antoine, R. , Barros Aguirre, D. , Baulard, A.R. , Bourotte, M. , Dale, G.E. , Deprez, B. , Dreneau, A. , Drewes, G. , Edoo, Z. , Frita, R. , Ghidelli-Disse, S. , Gitzinger, M. , Grosse, C. , Hofmann, L. , Jung, F. , Kemmer, C. , Lociuro, S. , Mathys, V. , Megalizzi, V. , Mendoza, A. , Moune, M. , Perez-Herran, E. , Pieren, M. , Rebollo Lopez, M.J. , Remuinan, M.D. , Schellhorn, B. , Soetaert, K. , Trebosc, V. , Willand, N. , Wintjens, R.
Date: 2023-12-07 Method: X-RAY DIFFRACTION Resolution: 1.494 Å Organism(s): Mycobacterium Tuberculosis H37Rv Sequences Data: 8RCX_A , 8RCX_B